CAVERNOUS SINUS THROMBOSIS

This adverse event was reported 254 times

These drugs are most commonly taken by patients reporting CAVERNOUS SINUS THROMBOSIS:

# Drug Count
0 PREDNISONE 28
1 METHOTREXATE SODIUM 26
2 METHOTREXATE 23
3 DEXAMETHASONE 21
4 DEXAMETHASONE 1.5 MG 21
5 PREDNISOLONE 18
6 PREDNISOLONE ORAL 18
7 PREDNISOLONE ORAL SOLUTION 18
8 TACROLIMUS 18
9 DROSPIRENONE AND ETHINYL ESTRADIOL 17
See all common drugs associated with CAVERNOUS SINUS THROMBOSIS

CAVERNOUS SINUS THROMBOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 USTEKINUMAB-AUUB 1 0.0057
1 TRIFAROTENE 1 0.0055
2 DELANDISTROGENE MOXEPARVOVEC-ROKL 1 0.0027
3 ACETAZOLAMIDE SODIUM 11 0.0018
4 VANCOMYCIN HYDROCHLORIDE 14 0.0017
5 CLINDAMYCIN PHOSPHATE 8 0.0014
6 SODIUM HYALURONATE 1 0.0012
7 AMPICILLIN AND SULBACTAM 1 0.0011
8 CALCIUM ACETATE 5 0.0009
9 ANTI-INHIBITOR COAGULANT COMPLEX 1 0.0009
See all drugs enriched for association with CAVERNOUS SINUS THROMBOSIS

CAVERNOUS SINUS THROMBOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Ergot Derivative [EPC] 4 0.0008
1 Carbonic Anhydrase Inhibitor [EPC] 11 0.0005
2 Echinocandin Antifungal [EPC] 4 0.0005
3 Asparagine-specific Enzyme [EPC] 6 0.0004
4 Antiparasitic [EPC] 2 0.0004
5 Pediculicide [EPC] 2 0.0004
6 Barbiturate [EPC] 3 0.0003
7 Lipid-based Polyene Antifungal [EPC] 3 0.0002
8 Glycopeptide Antibacterial [EPC] 14 0.0002
9 Gadolinium-based Contrast Agent [EPC] 1 0.0002
See all drug classes enriched for association with CAVERNOUS SINUS THROMBOSIS